145 related articles for article (PubMed ID: 17870260)
1. Effects of tibolone and raloxifene on health-related quality of life and sexual function.
Nijland EA; Weijmar Schultz WC; Davis SR
Maturitas; 2007 Oct; 58(2):164-73. PubMed ID: 17870260
[TBL] [Abstract][Full Text] [Related]
2. Quality of life and sexuality changes in postmenopausal women receiving tibolone therapy.
Wu MH; Pan HA; Wang ST; Hsu CC; Chang FM; Huang KE
Climacteric; 2001 Dec; 4(4):314-9. PubMed ID: 11770188
[TBL] [Abstract][Full Text] [Related]
3. Effect of raloxifene on sexual function in postmenopausal women.
Kessel B; Nachtigall L; Plouffe L; Siddhanti S; Rosen A; Parsons A
Climacteric; 2003 Sep; 6(3):248-56. PubMed ID: 14567773
[TBL] [Abstract][Full Text] [Related]
4. A comparison of raloxifene and calcium plus vitamin D on vaginal atrophy after discontinuation of long-standing postmenopausal hormone therapy in osteoporotic women. A randomized, masked-evaluator, one-year, prospective study.
Checa MA; Garrido A; Prat M; Conangla M; Rueda C; Carreras R
Maturitas; 2005 Sep; 52(1):70-7. PubMed ID: 16143228
[TBL] [Abstract][Full Text] [Related]
5. Clitoral circulation in postmenopausal women with sexual dysfunction: a pilot randomized study with hormone therapy.
Nappi RE; Ferdeghini F; Sampaolo P; Vaccaro P; De Leonardis C; Albani F; Salonia A; Polatti F
Maturitas; 2006 Oct; 55(3):288-95. PubMed ID: 16730929
[TBL] [Abstract][Full Text] [Related]
6. A 5-year study on the effect of hormone therapy, tibolone and raloxifene on vaginal bleeding and endometrial thickness.
Christodoulakos GE; Botsis DS; Lambrinoudaki IV; Papagianni VD; Panoulis CP; Creatsa MG; Alexandrou AP; Augoulea AD; Dendrinos SG; Creatsas GC
Maturitas; 2006 Mar; 53(4):413-23. PubMed ID: 16140483
[TBL] [Abstract][Full Text] [Related]
7. Effect on sexual life--a comparison between tibolone and continuous combined conjugated equine estrogens and medroxyprogesterone acetate.
Uygur D; Yeşildaglar N; Erkaya S
Gynecol Endocrinol; 2005 Apr; 20(4):209-12. PubMed ID: 16019363
[TBL] [Abstract][Full Text] [Related]
8. Effect of different preparations of hormone therapy on sexual dysfunction in naturally postmenopausal women.
Osmanağaoğlu MA; Atasaral T; Baltaci D; Bozkaya H
Climacteric; 2006 Dec; 9(6):464-72. PubMed ID: 17085380
[TBL] [Abstract][Full Text] [Related]
9. The effects of tibolone on vaginal blood flow, sexual desire and arousability in postmenopausal women.
Laan E; van Lunsen RH; Everaerd W
Climacteric; 2001 Mar; 4(1):28-41. PubMed ID: 11379375
[TBL] [Abstract][Full Text] [Related]
10. Tibolone for the treatment of moderate to severe vasomotor symptoms and genital atrophy in postmenopausal women: a multicenter, randomized, double-blind, placebo-controlled study.
Swanson SG; Drosman S; Helmond FA; Stathopoulos VM
Menopause; 2006; 13(6):917-25. PubMed ID: 17006377
[TBL] [Abstract][Full Text] [Related]
11. Serum leptin levels and body composition in postmenopausal women treated with tibolone and raloxifene.
Tommaselli GA; Di Carlo C; Di Spiezio Sardo A; Bifulco G; Cirillo D; Guida M; Capasso R; Nappi C
Menopause; 2006; 13(4):660-8. PubMed ID: 16837888
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of oral tibolone 1.25 or 2.5 mg/day vs. placebo in postmenopausal women.
Hudita D; Posea C; Ceausu I; Rusu M
Eur Rev Med Pharmacol Sci; 2003; 7(5):117-25. PubMed ID: 15214586
[TBL] [Abstract][Full Text] [Related]
13. Clinical effects of tibolone in postmenopausal women after 5 years of tamoxifen therapy for breast cancer.
Dimitrakakis C; Keramopoulos D; Vourli G; Gaki V; Bredakis N; Keramopoulos A
Climacteric; 2005 Dec; 8(4):342-51. PubMed ID: 16390769
[TBL] [Abstract][Full Text] [Related]
14. Tibolone relieves climacteric symptoms in highly symptomatic women with at least seven hot flushes and sweats per day.
Landgren MB; Helmond FA; Engelen S
Maturitas; 2005 Mar; 50(3):222-30. PubMed ID: 15734603
[TBL] [Abstract][Full Text] [Related]
15. Tibolone: clinical recommendations and practical guidelines. A report of the International Tibolone Consensus Group.
Kenemans P; Speroff L;
Maturitas; 2005 May; 51(1):21-8. PubMed ID: 15883105
[TBL] [Abstract][Full Text] [Related]
16. [Acceptability of continuous combined versus cyclical HRT: a French multicentric randomized clinical study].
Drapier-Faure E; Azoulay C; Abramovici Y
Gynecol Obstet Fertil; 2005; 33(7-8):498-504. PubMed ID: 16005674
[TBL] [Abstract][Full Text] [Related]
17. Significant differential effects of lower doses of hormone therapy or tibolone on markers of cardiovascular disease in post-menopausal women: a randomized, double-blind, crossover study.
Koh KK; Han SH; Shin MS; Ahn JY; Lee Y; Shin EK
Eur Heart J; 2005 Jul; 26(14):1362-8. PubMed ID: 15872028
[TBL] [Abstract][Full Text] [Related]
18. Effects of a standardized ginseng extract on quality of life and physiological parameters in symptomatic postmenopausal women: a double-blind, placebo-controlled trial. Swedish Alternative Medicine Group.
Wiklund IK; Mattsson LA; Lindgren R; Limoni C
Int J Clin Pharmacol Res; 1999; 19(3):89-99. PubMed ID: 10761538
[TBL] [Abstract][Full Text] [Related]
19. Differential prevalence of quality-of-life categories (domains) in Asian women and changes after therapy with three doses of conjugated estrogens/medroxyprogesterone acetate: the Pan-Asia Menopause (PAM) study.
Limpaphayom KK; Darmasetiawan MS; Hussain RI; Burriss SW; Holinka CF; Ausmanas MK
Climacteric; 2006 Jun; 9(3):204-14. PubMed ID: 16766434
[TBL] [Abstract][Full Text] [Related]
20. Effects of resveratrol, raloxifene, tibolone and conjugated equine estrogen on vaginal squamous cell maturation of ovariectomized rats.
Hascalik S; Celik O; Tamser M; Mizrak B
Gynecol Obstet Invest; 2005; 60(4):186-91. PubMed ID: 16020933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]